Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report

BACKGROUND: The advent of immune checkpoint inhibitors (ICIs) has revolutionized the management of several types of solid cancers, including lung cancer, by boosting the body's natural tumor killing response. However, it is undeniable that only a small proportion of non-small cell lung cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ding, Cheng, Cheng, Song, Wen-Ping, Ni, Pei-Zan, Zhang, Wen-Zhou, Wu, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717509/
https://www.ncbi.nlm.nih.gov/pubmed/35071573
http://dx.doi.org/10.12998/wjcc.v9.i36.11419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717509/
https://www.ncbi.nlm.nih.gov/pubmed/35071573
http://dx.doi.org/10.12998/wjcc.v9.i36.11419

Ejemplares similares